Bài viết trình bày những tiến bộ ung thư dạ dày 2017-2019 so với ung thư dạ dày 2010-2013 trong định bệnh, điều trị và kết quả. Mặc dù định bệnh khá hơn, phẫu thuật tích cực nhóm sau nhiều hơn, đặc biệt là nội soi, hóa trị và theo dõi cũng khá hơn. Trong 18 tháng, nhóm mổ tích cực: sống 40%, nhóm mổ tạm: sống 9%.
nationwide Duch DID2 trial Lancet Oncol 11: 439 - 449, 2010 17 Bang YJ, Van Cutsem E, Feyercislova A, et al: Trastuzumab in combinaison with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastroesophageal junction cancer, A phase 3, open label, randomized controlled trial Lancet 376:687 - 697, 2010 11 Jiang I, Yang KH, Guan QL et al: Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer 275 Tạp chí Ung thư học Việt Nam Số - 2020 - Tập Journal of Oncology Viet Nam - Issue N5 - 2020 - Vol ABSTRACT Progressive of gastric cancer treatment in 2017 - 2019 About year ago, in the department No1, the cancer of stomach in 2017 - 2019 are smaller (617) in comparison of 2010 - 2012 (1.191), because there is a new department Objective: A review of diagnosis, of treatment and of results in middle term Method: Retrospective Patients: 2000 - 2013, male/female 1,8 Average age: 57 - 2017 - 2019 male/ female 3/2 Average age 62, male 63, female 60 - First group: Douleur of epigastre 72% vomiting, dysphagia, melena; - Second group douleur of epigastre 80% vomiting 8%, decrease of weight 8%, melena 3% - Average pain of the first group: months - Pain of the second group: month 8%, month 9%,3 month 24%,4 month 7% - CT scan, endoscopy showed the diagnosis 2010 - 2013 2017 - 2019 Grade Lapasos Open OP Grade Lapasos Open OP T1A (1%) (0%) T1A 4% 0% T2A (2%) (1%) T2A 8% 0% T2B 11 (11%) (2%) T2B 12% 0% T3A 36 (36%) 22 (22%) T3A 60% 12% T3B 41 (41%) 63 (63%) T3B 52% 13% T4A (0%) 12 (12%) T4A 8% 4% Operation: There are new techniques, the robot endoscopy, the EUS - 2010 - 2012: gastrectomy (22%): ¼ laparoscopy, partial or totaL or subtotal, (3,6%) 43 cases - 2017 - 2019: gastrectomy (36%): ¾ laparoscopy, partial or total or subtotal (8,5%) 54 cases - 2010 - 2012: palliative surgery 460 (43%), gastroenteroscopy, entero-enteroscopy, entero-coloscopy, enterotomy, biopsy - 2017 - 2019, palliative surgery 147 (24%): gastroenteroscopy, entero-enteroscopy, entero-coloscopy, enterotomy, biopsy - 2010 - 2012, conservative 370, (35%) - 2017 - 2018 conservative 210 (34%) So, in the department of TQ1, admission after about years the number is smaller because in the year 2015 there is a new department The grade of cancer has a progression The curative operation is 36%/ 22% Because the technique is more advanced, speciality laparoscopy is 3/4 in comparison 1/4 Subtotal gastrectomy or total gastrectomy is 8,5% in comparison 3,6% In case of palliative operation is 24% in comparison 43% because in cases of curative operation increased Discussion and conclusion: The diagnosis has a progression The treatment is advanced, so the curative operation is more than first group, speciality, laparoscopy and chemotherapy are more The follow up is better, after 18 months, the curative is still living 40%, the palliative 9% Key word: Gastrectomy 2017 - 2019 in comparison with 2010 - 2013 at BD hospital 276 ... speciality laparoscopy is 3/4 in comparison 1/4 Subtotal gastrectomy or total gastrectomy is 8,5% in comparison 3,6% In case of palliative operation is 24% in comparison 43% because in cases of curative... month 7% - CT scan, endoscopy showed the diagnosis 2010 - 2013 2017 - 2019 Grade Lapasos Open OP Grade Lapasos Open OP T1A (1%) (0%) T1A 4% 0% T2A (2%) (1%) T2A 8% 0% T2B 11 (11%) (2%) T2B 12%...Tạp chí Ung thư học Việt Nam Số - 2020 - Tập Journal of Oncology Viet Nam - Issue N5 - 2020 - Vol ABSTRACT